Fee schedule for industry-sponsored trials, regardless of protocol authorship, company or IIT. Effective January 1, 2026.
HRP-700 | Version Date: 1/1/2026
- If the study requires more than one continuing review in a year, only one fee will be collected for that year.
- If there is both a coordinating center application and a site protocol, the fee is only collected on the site protocol.
- There may be circumstances when the industry collaborator is not funding the entire study but is supporting it by providing only the drug/device. In this scenario, the investigator can request a waiver of the fee.
- The review fee is collected or waived by the Business Manager through an ancillary review process.
- Fee sheets should be uploaded into the PittPRO application on the Study Funding Source page under question #2, sub-question 4.
Contact the Business Manager of the Office of Research Protections with questions: sak168@pitt.edu
If you are requesting a waiver of the industry fee, a written justification must be provided. All requests must be submitted to the HRPO Business Manager at sak168@pitt.edu.
Full Board Review
Initial Application $2,500
Continuing Review $1,500
Expedited / Exempt Review
Initial Application $2,000
Continuing Review $1,000
Full Board Review
Initial Application $3,000
Continuing Review $2,000
Study-Wide Sponsor Initiated Amendment $1,000
Study Close-Out $600
Expedited / Exempt Review
Expedited Initial Application $3,000
Continuing Review $1,500
Exempt Initial Application $1,000
Study-Wide Sponsor Initiated Amendment $1,000
Study Close-Out $600
University of Pittsburgh | Office of Research Protections | orp_support@pitt.edu
Document HRP-700 | Version Date: 1/1/2026